|
Development of an automated Umbilical Cord Blood Hematopoietic Stem Cell expansio
|
1R43CA200369-01
|
$185,500
|
|
NOLAN, DANIEL
|
ANGIOCRINE BIOSCIENCE, INC.
|
|
Stand and Move at Work: A Group-Randomized Trial
|
1R01CA198971-01
|
$639,042
|
|
BUMAN, MATTHEW
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xen
|
1U01CA199288-01
|
$604,258
|
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational control of EMT by the CELF1 RNA Binding Protein
|
1R01CA190467-01A1
|
$362,569
|
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Prospective Identification of Translational Regulators in EMT
|
1R21CA185769-01A1
|
$206,843
|
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Notch Signaling in Prostate Homeostasis and Carcinogenesis
|
1R01CA190378-01A1
|
$362,569
|
|
XIN, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
1U01CA199252-01
|
$1,080,326
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
1U01CA187508-01A1
|
$498,385
|
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Enzyme-instructed self-assembly for molecular anticancer nanomedicines
|
2R01CA142746-06A1
|
$383,751
|
|
XU, BING
|
BRANDEIS UNIVERSITY
|
|
Murine Models on SALL4 in Hepatocellular Carcinoma
|
1R03CA184531-01A1
|
$81,724
|
|
CHAI, LI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Systematic identification of oncogenic KRAS synthetic lethal interactions
|
1U01CA199253-01
|
$817,805
|
|
HAHN, WILLIAM
|
BROAD INSTITUTE, INC.
|
|
Using Behavioral Economics to Promote Exercise among Inactive Overweight Adults
|
1R03CA188473-01A1
|
$81,250
|
|
WILLIAMS, DAVID
|
BROWN UNIVERSITY
|
|
Risk factors for breast cancer subtypes in racial/ethnic minorities
|
1R03CA199343-01
|
$74,500
|
|
JOHN, ESTHER
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
PET Kinetic Modeling of Inhibiting Glycolysis in Ovarian Cancer
|
1R21CA198795-01
|
$185,247
|
|
AVRIL, NORBERT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting an MT1-MMP/MMP2 axis in melanoma by a novel MT1-MMP/MMP2 inhibitor
|
1R21CA187695-01A1
|
$217,926
|
|
BEDOGNI, BARBARA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Identifying a network of miRNAs and genes that regulate breast tumor metastasis
|
3R00CA160638-03S1
|
$57,024
|
|
LIU, HUIPING
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Pathology Image Informatics Platform for visualization, analysis and management
|
1U24CA199374-01
|
$606,305
|
|
MADABHUSHI, ANANT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Natural Agent in Prevention of Prostate Cancer
|
1R21CA190921-01A1
|
$172,369
|
|
SHUKLA, SANJEEV
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors
|
2R01CA129822-05A1
|
$374,063
|
|
MEDINA-KAUWE, LALI
|
CEDARS-SINAI MEDICAL CENTER
|
|
The Impact of Macrophage Polarization on the Efficacy of Radiation Therapy
|
1K08CA191139-01A1
|
$176,796
|
|
SHIAO, STEPHEN
|
CEDARS-SINAI MEDICAL CENTER
|
|
TissueCypher Testing for Risk Assessment in Barretts Esophagus
|
1R44CA192416-01A1
|
$624,917
|
|
CRITCHLEY-THORNE, REBECCA
|
CERNOSTICS, INC.
|
|
Pediatric Cancer Interdisciplinary Team Training for Regoaling CARE Discussions
|
1R21CA198049-01
|
$219,240
|
|
FEUDTNER, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Pediatric Preclinical Testing Consortium
|
1U01CA199287-01
|
$357,000
|
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Gender Difference in Bladder Cancer Susceptibility
|
1R21CA198544-01
|
$192,216
|
|
LI, XUE
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Novel Role of Honokiol in Preventing Cancer during Immune Suppression
|
1R21CA191735-01A1
|
$236,488
|
|
PAL, SOUMITRO
|
CHILDREN'S HOSPITAL CORPORATION
|
|
THE ROLE OF LIN28B IN WILMS TUMOR
|
5F31CA186444-02
|
$35,440
|
|
YERMALOVICH, ALENA
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM
|
1R21CA185875-01A1
|
$207,513
|
|
SMITH, EILEEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Dynamic Complexity of Brain Tumor Stem Cells
|
1R35CA197718-01
|
$951,000
|
|
RICH, JEREMY
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Protein Tyrosine Dephosphorylation & Signal Transduction
|
2R01CA053840-24
|
$776,676
|
|
TONKS, NICHOLAS
|
COLD SPRING HARBOR LABORATORY
|
|
Functional dissection of oncogenic enhancers
|
1K99CA197869-01
|
$170,856
|
|
HERRANZ BENITO, DANIEL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Novel Roles for Oncogenic SOX2 in Esophageal Squamous Cell Carcinoma
|
1R01CA187119-01A1
|
$383,831
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Overcoming resistance to targeted therapy in cancer
|
1R35CA197737-01
|
$473,472
|
|
GARRAWAY, LEVI
|
DANA-FARBER CANCER INST
|
|
Investigating a Novel Glutamine Metabolism Pathway in Pancreatic Cancer
|
1R01CA188048-01A1
|
$353,696
|
|
KIMMELMAN, ALEC
|
DANA-FARBER CANCER INST
|
|
Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia
|
1K08CA191091-01A1
|
$177,120
|
|
KNOECHEL, BIRGIT
|
DANA-FARBER CANCER INST
|
|
Determining the mutational landscape of circulating multiple myeloma cells
|
1K08CA191026-01A1
|
$177,120
|
|
LOHR, JENS
|
DANA-FARBER CANCER INST
|
|
Multi-probe fluorescence imaging for rapid intra-operative tumor margin assessmen
|
1R01CA188491-01A1
|
$556,961
|
|
DAVIS, SCOTT
|
DARTMOUTH COLLEGE
|
|
Occupational Pesticide Use and Risk of Lymphoid Cancers
|
1R03CA199515-01
|
$78,250
|
|
DE ROOS, ANNECLAIRE
|
DREXEL UNIVERSITY
|
|
Reducing Cancer Risk by Training Response Inhibition to Obesogenic Foods
|
1R21CA191859-01A1
|
$192,435
|
|
FORMAN, EVAN
|
DREXEL UNIVERSITY
|
|
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer
|
3R01CA120206-09S1
|
$16,465
|
|
MEHTA, ANAND
|
DREXEL UNIVERSITY
|
|
The role of dietary copper in melanoma
|
1R01CA177587-01A1
|
$363,713
|
|
COUNTER, CHRISTOPHER
|
DUKE UNIVERSITY
|
|
Targeted Chemoprevention of Br Ca: From Bench to Clinical Testing Minority Suppl
|
3R01CA158668-04S1
|
$103,153
|
|
SEEWALDT, VICTORIA
|
DUKE UNIVERSITY
|
|
AR variant regulation during EMT and disease progression
|
1F32CA192630-01A1
|
$54,194
|
|
WARE, KATHRYN
|
DUKE UNIVERSITY
|
|
Aptamers as Proteomic Tools for Pancreatic Cancer Biomarker Identification
|
1R21CA198287-01
|
$207,495
|
|
WHITE, REBEKAH
|
DUKE UNIVERSITY
|
|
THE ROLE OF MALT1 IN MELANOMA GROWTH AND METASTASIS
|
1R03CA188619-01A1
|
$79,500
|
|
ZHANG, YUNYAN JENNIFER
|
DUKE UNIVERSITY
|
|
Targeting Rev1-mediated Translesion Synthesis for Cancer Therapy
|
1R21CA191448-01A1
|
$197,466
|
|
ZHOU, PEI
|
DUKE UNIVERSITY
|
|
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
|
3R01CA176001-02S1
|
$48,411
|
|
GROSSNIKLAUS, HANS
|
EMORY UNIVERSITY
|
|
New and integrated perspectives on modification of tamoxifen effectiveness
|
3R01CA166825-03S1
|
$98,940
|
|
LASH, TIMOTHY
|
EMORY UNIVERSITY
|
|
Role of B cells in murine gammaherpesvirus 68
|
2R01CA095318-11A1
|
$368,305
|
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Promote HPV screening rate with a non-invasive HPV POC cartridge
|
1R43CA199211-01
|
$223,629
|
|
GAU, VINCENT
|
GENEFLUIDICS, INC.
|
|
Glycans in Hepatocellular Carcinoma
|
2R01CA135069-06A1
|
$417,481
|
|
GOLDMAN, RADOSLAV
|
GEORGETOWN UNIVERSITY
|
Total relevant funding to Inflammatory Bowel Disease for this search: $3,102,212
|